Results 31 to 40 of about 7,733 (208)

DataSheet1_Hydralazine Associated With Reduced Therapeutic Phlebotomy Frequency in a Nationwide Cohort Study: Real-World Effectiveness for Drug Repurposing.docx

, 2022
Background: Therapeutic phlebotomy, known as scheduled bloodletting, has been the main method for managing erythrocytosis symptoms and thrombocytosis-associated complications in various blood disorders.
Chi-Hsiang Chung (306301), Chia-Yang Shaiu (12331790), Bing-Heng Yang (12034139), Wei-Zhi Lin (11574688), Wu-Chien Chien (306300)   +4 more
core   +1 more source

USO TERAPÊUTICO DE SANGRIAS: UMA REVISÃO DE LITERATURA

Hematology, Transfusion and Cell Therapy, 2021
Objetivos: A flebotomia terapêutica é um método de retirada de sangue, de modo a tratar e prevenir diversas condições tóxicas para o organismo.
ALM Lopes, JSI Chaves, JPL Cezar
doaj   +1 more source

Editorial: therapeutic phlebotomy for iron overload—start with a diagnosis before bleeding [PDF]

Alimentary Pharmacology & Therapeutics, 2022
LINKED CONTENTThis article is linked to LeGac et al papers.
openaire   +2 more sources

Indications and Contraindications of Phlebotomy According to Avicenna in Al-Qanun fi al-Tibb (The Canon of Medicine) [PDF]

Journal of Research on History of Medicine
Today, phlebotomy has a limited application in modern medicine and is prescribed for only a few specific conditions. However, recent studies have explored its potential effectiveness in treating a broader range of diseases. As phlebotomy has historically
Shahram Homayounkeshi, Majid Talafi Noghani   +1 more
doaj   +1 more source

A Study of Indications, Clinical Applications, and Effects of Therapeutic Phlebotomy at a Tertiary Care Hospital Navi Mumbai

Global Journal of Transfusion Medicine
Background and Objectives: The removal of blood from the body is known as phlebotomy, venesection, or bloodletting. Therapeutic phlebotomy is the preferred treatment for blood disorders where removing red blood cells or serum iron is the most effective ...
Sonal Suresh Gupta, Shweta Wasudeo Dhote, Shubhangi Lad, Damayanti Radhashyam Dey   +3 more
doaj   +1 more source

Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports

Orphanet Journal of Rare Diseases, 2020
Background Aceruloplasminemia is a rare genetic iron overload disorder, characterized by progressive neurological manifestations. The effects of iron chelation on neurological outcomes have only been described in case studies, and are inconsistent ...
Lena H. P. Vroegindeweij, Agnita J. W. Boon, J. H. Paul Wilson, Janneke G. Langendonk   +3 more
doaj   +1 more source

Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy

Molecular Genetics and Metabolism Reports, 2021
Congenital erythropoietic porphyria (CEP) is an autosomal recessive disorder of the heme biosynthetic pathway that is characterized by uroporphyrinogen III synthase (UROS) deficiency and the accumulation of non-physiological isomer I porphyrins.
Jean-Marc Blouin, Cécile Ged, Ganeko Bernardo-Seisdedos, Txomin Cabantous, Benoît Pinson, Antoine Poli, Hervé Puy, Oscar Millet, Laurent Gouya, Fanny Morice-Picard, Emmanuel Richard   +10 more
doaj   +1 more source

Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?

Endocrine Connections
Erythrocytosis, or elevated hematocrit, is a common side effect of testosterone therapy (TTh) in male hypogonadism. Testosterone stimulates erythropoiesis through an initial rise in erythropoietin (EPO), the establishment of a new EPO/hemoglobin ‘set ...
Peter Bond, Tijs Verdegaal, Diederik L Smit   +2 more
doaj   +1 more source

Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion‐Dependent β‐Thalassemia

American Journal of Hematology, EarlyView.
ABSTRACT Exagamglogene autotemcel (exa‐cel) is a one‐time, ex vivo, CRISPR‐Cas9 gene edited cell therapy approved for patients with transfusion dependent β‐thalassemia (TDT) aged 12–35 years. In a Phase 3 study (CLIMB THAL‐111), exa‐cel treatment resulted in reactivation of fetal hemoglobin and increases in total hemoglobin, leading to transfusion ...
Sujit Sheth, Selim Corbacioglu, Josu de la Fuente, Mattia Algeri, Joachim Rupprecht, Kevin H. M. Kuo, Ami J. Shah, Peter Lang, Hayley Merkeley, Ben Carpenter, Markus Y. Mapara, Robert I. Liem, Stephan Grupp, Yogi Chopra, Amanda M. Li, Janet L. Kwiatkowski, Melanie Kirby‐Allen, Maria Domenica Cappellini, Antonis Kattamis, Sakellarios Zairis, Tina Liu, William Hobbs, Haydar Frangoul, Franco Locatelli, Roland Meisel, on behalf of the CLIMB THAL‐111 and CLIMB‐131 Study Groups   +25 more
wiley   +1 more source

Therapeutic phlebotomy

, 1999
A sangria terapêutica é método paliativo de controle de sintomas, simples e antigo, que se mostra eficaz também a longo prazo, melhorando a expectativa e a qualidade de vida.
Papa, Fábio V., Angulo, Ivan L., Cardoso, Fernanda G.   +2 more
core   +1 more source